Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salbutamol in elective caesarean section
2012-001912-53Phase 2Terminated
- Sponsor
- Children's Hospital, Helsinki University Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of salbutamol in transient tachypnea of the newborn (TTN), sponsored by Children's Hospital, Helsinki University Hospital. Primary endpoints: Lung compliance at 3–6 hours of age and Transthoracic lung ultrasound measurements at 3–6 hours of age. Started Nov 2012; status: terminated.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on 2012-001912-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001912-53.